Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide

Hypertension

Volumn 61, Issue 4, 2013, Pages 793-799

  Salvi, Paolo ^a   Revera, Miriam ^a   Faini, Andrea ^a   Giuliano, Andrea ^a   Gregorini, Francesca ^a   Agostoni, Piergiuseppe ^d   Becerra, Carlos G ^a   Bilo, Grzegorz ^a   Lombardi, Carolina ^a   O'Rourke, Michael F ^e   Mancia, Giuseppe ^a,c   Parati, Gianfranco ^a,b,c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b Department of Cardiology ^*  (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

acetazolamide; altitude; arterial stiffness; hypobaric hypoxia; myocardial oxygen demand; pulse wave analysis

Indexed keywords

ACETAZOLAMIDE; PLACEBO;

ADULT; ALTITUDE; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; ENDOCARDIUM; FEMALE; HEART MUSCLE PERFUSION; HEART PROTECTION; HUMAN; HYPOXIA; MALE; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEA LEVEL; TONOMETER; VALIDATION STUDY;

ACETAZOLAMIDE; ACUTE DISEASE; ADULT; ALTITUDE SICKNESS; CARBONIC ANHYDRASE INHIBITORS; CORONARY CIRCULATION; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875211260     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00707     Document Type: Article

References (46)

1. Alexander JK. Coronary problems associated with altitude and air travel. Cardiol Clin. 1995;13:271-278.
2. Bärtsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation. 2007;116:2191-2202.
3. Bilo G, Caldara G, Styczkiewicz K, Revera M, Lombardi C, Giglio A, Zambon A, Corrao G, Faini A, Valentini M, Mancia G, Parati G. Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude. J Hypertens. 2011;29:380-387.
4. Buckberg GD, Fixler DE, Archie JP, Hoffman JI. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res. 1972;30:67-81.
5. Buckberg GD, Towers B, Paglia DE, Mulder DG, Maloney JV. Subendocardial ischemia after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1972;64:669-684.
6. Hoffman JI, Buckberg GD. Pathophysiology of subendocardial ischaemia. Br Med J. 1975;1:76-79.
7. Hoffman JI, Buckberg GD. The myocardial supply:demand ratio: A critical review. Am J Cardiol. 1978;41:327-332.
8. Brazier J, Cooper N, Buckberg G. The adequacy of subendocardial oxygen delivery: the interaction of determinants of flow, arterial oxygen content and myocardial oxygen need. Circulation. 1974;49:968-977.
9. Nichols W, O'Rourke M, Vlachopoulos C. Mcdonald's blood flow in arteries. Theoretical, Experimental and Clinical Principles. 6th ed. New York, NY: Oxford University Press; 2011.
10. Birmingham Medical Research Expeditionary Society Mountain Sickness Study Group. Acetazolamide in control of acute mountain sickness. Lancet. 1981;1:180-183.
11. Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol. 2007;102:1313-1322.
12. Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention, and treatment. Prog Cardiovasc Dis. 2010;52:467-484.
13. Salvi P. Pulse Waves. How Vascular Hemodynamics Affects Blood Pressure. Milan, Italy: Springer; 2012.
14. Chemla D, Nitenberg A, Teboul JL, Richard C, Monnet X, le Clesiau H, Valensi P, Brahimi M. Subendocardial viability index is related to the diastolic/systolic time ratio and left ventricular filling pressure, not to aortic pressure: an invasive study in resting humans. Clin Exp Pharmacol Physiol. 2009;36:413-418.
15. Barnard RJ, MacAlpin R, Kattus AA, Buckberg GD. Ischemic response to sudden strenuous exercise in healthy men. Circulation. 1973;48:936-942.
16. Griggs DM Jr, Chen CC. Coronary hemodynamics and regional myocardial metabolism in experimental aortic insufficiency. J Clin Invest. 1974;53:1599-1606.
17. Salvi P, Lio G, Labat C, Ricci E, Pannier B, Benetos A. Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity: the PulsePen device. J Hypertens. 2004;22:2285-2293.
18. Joly L, Perret-Guillaume C, Kearney-Schwartz A, Salvi P, Mandry D, Marie PY, Karcher G, Rossignol P, Zannad F, Benetos A. Pulse wave velocity assessment by external noninvasive devices and phase-contrast magnetic resonance imaging in the obese. Hypertension. 2009;54:421-426.
19. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605.
20. Roach R, Bärtsch P, Oelz O, Hackett PH. The lake louise acute mountain sickness scoring system. Hypoxia and Molecular Medicine. Burlington, VT: Queen City Press; 1993.
21. Sarnoff SJ, Braunwald E, Welch GH Jr, Case RB, Stainsby WN, Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol. 1958;192:148-156.
22. Gutterman DD, Cowley AW Jr. Relating cardiac performance with oxygen consumption: historical observations continue to spawn scientific discovery. Am J Physiol Heart Circ Physiol. 2006;291:H2555-H2556.
23. Neely JR, Liebermeister H, Battersby EJ, Morgan HE. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol. 1967;212:804-814.
24. Merkus D, Kajiya F, Vink H, Vergroesen I, Dankelman J, Goto M, Spaan JA. Prolonged diastolic time fraction protects myocardial perfusion when coronary blood flow is reduced. Circulation. 1999;100:75-81.
25. Indolfi C, Ross J Jr. The role of heart rate in myocardial ischemia and infarction: implications of myocardial perfusion-contraction matching. Prog Cardiovasc Dis. 1993;36:61-74.
26. Fokkema DS, VanTeeffelen JW, Dekker S, Vergroesen I, Reitsma JB, Spaan JA. Diastolic time fraction as a determinant of subendocardial perfusion. Am J Physiol Heart Circ Physiol. 2005;288:H2450-H2456.
27. Ferro G, Duilio C, Spinelli L, Liucci GA, Mazza F, Indolfi C. Relation between diastolic perfusion time and coronary artery stenosis during stress-induced myocardial ischemia. Circulation. 1995;92:342-347.
28. Tsiachris D, Tsioufis C, Syrseloudis D, Roussos D, Tatsis I, Dimitriadis K, Toutouzas K, Tsiamis E, Stefanadis C. Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens. 2012;26:64-70.
29. Baller D, Bretschneider HJ, Hellige G. A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res Cardiol. 1981;76:163-181.
30. Chemla D, Nitenberg A, Teboul JL, Richard C, Monnet X, le Clesiau H, Valensi P, Brahimi M. Subendocardial viability ratio estimated by arterial tonometry: a critical evaluation in elderly hypertensive patients with increased aortic stiffness. Clin Exp Pharmacol Physiol. 2008;35:909-915.
31. O'Rourke MF. How stiffening of the aorta and elastic arteries leads to compromised coronary flow. Heart. 2008;94:690-691.
32. Watanabe H, Ohtsuka S, Kakihana M, Sugishita Y. Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol. 1993;21:1497-1506.
33. Lewis RP, Boudoulas H, Forester WF, Weissler AM. Shortening of electromechanical systole as a manifestation of excessive adrenergic stimulation in acute myocardial infarction. Circulation. 1972;46:856-862.
34. Koller EA, Drechsel S, Hess T, Macherel P, Boutellier U. Effects of atropine and propranolol on the respiratory, circulatory, and ECG responses to high altitude in man. Eur J Appl Physiol Occup Physiol. 1988;57:163-172.
35. Braunwald E, Sarnoff SJ, Stainsby WN. Determinants of duration and mean rate of ventricular ejection. Circ Res. 1958;6:319-325.
36. Parati G, Revera M, Giuliano A, Faini A, Bilo G, Gregorini F, Lisi E, Salerno S, Lombardi C, Ramos Becerra CG, Mancia G, Salvi P. Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure. Eur Heart J. (in press) doi:10.1093/eurheartj-ehs140.
37. Marshall JM. Peripheral chemoreceptors and cardiovascular regulation. Physiol Rev. 1994;74:543-594.
38. Richalet JP, Larmignat P, Rathat C, Kéromès A, Baud P, Lhoste F. Decreased cardiac response to isoproterenol infusion in acute and chronic hypoxia. J Appl Physiol. 1988;65:1957-1961.
39. Teppema LJ, Dahan A. Acetazolamide and breathing. Does a clinical dose alter peripheral and central CO(2) sensitivity? Am J Respir Crit Care Med. 1999;160(5 pt 1):1592-1597.
40. Hanson MA, Nye PC, Torrance RW. The location of carbonic anhydrase in relation to the blood-brain barrier at the medullary chemoreceptors of the cat. J Physiol (Lond). 1981;320:113-125.
41. Lahiri S, Mulligan E, Mokashi A. Adaptive response of carotid body chemoreceptors to CO2. Brain Res. 1982;234:137-147.
42. Ried L, Carter K, Ellsworth A. Acetazolamide or dexamethasone for prevention of acute mountain sickness. A meta-analysis. J Wilderness Med. 1994;5:34-48.
43. Swenson ER, Hughes JM. Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol. 1993;74:230-237.
44. Swenson ER, Leatham KL, Roach RC, Schoene RB, Mills WJ Jr, Hackett PH. Renal carbonic anhydrase inhibition reduces high altitude sleep periodic breathing. Respir Physiol. 1991;86:333-343.
45. Sutton JR, Houston CS, Mansell AL, McFadden MD, Hackett PM, Rigg JR, Powles AC. Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med. 1979;301:1329-1331.
46. Latshang TD, Nussbaumer-Ochsner Y, Henn RM, Ulrich S, Lo Cascio CM, Ledergerber B, Kohler M, Bloch KE. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial. JAMA. 2012;308:2390-2398.